Sunday, May 3, 2026
Home Blog Page 277

Is It Time To Stop Using The Word Marijuana?

0

Perhaps now as the country continues to legalize the substance, it’s time to say goodbye to marijuana and just stick to cannabis, the way we did before this whole marijuana madness began.

In recent years, society has shown interest in correcting centuries of historically hurtful symbolism and terminology. As people begin to dig deeper into this country’s often-problematic past, more and more words and phrases have revealed their racist origins.

There are a wide array of still-commonly used phrases that some suggest should be examined further. Common terms like “Black Market,” used widely in conversation about cannabis culture and all business, according to Reader’s Digest, is just one example of a phrase with racist roots. Even the term marijuana, a term so common and accepted that it has even found itself in modern legislation, is a word that many say should be canceled for good.

The word marijuana is the widely used term to describe cannabis that contains THC. However, it was not the first term Americans used to describe the psychedelic, and its origins are not at all scientific. 

marijuana education
Photo by eyegelb/Getty Images

RELATED: Cannabis, Marijuana And Hemp — What Is The Difference, Exactly?

The creation of the word marijuana is rather dark, and altogether troublesome. “In fact, the term entered the national consciousness in 1937 when it was used by the federal government as part of an effort to discriminate against Latinos,” said Ángel Cruz, NHCSL President and Pennsylvania State Representative.

Before this fictitious and racially motivated campaign, cannabis was the most commonly used term to describe the then legal flowering plant. “The use of the term increased dramatically in the 1930s, when it was systematically employed by Harry Anslinger, the director of the Federal Bureau of Narcotics, who waged a three-decade long campaign against cannabis,” according to the Ottawa Citizen

The term marijuana was popularized when politicians like Aslinger used the word to scare the American people into thinking cannabis was a dangerous substance used by violent minorities, hence the exotic sounding name.

“Fear of brown people combined with fear of nightmare drugs used by brown people to produce a wave of public action against the ‘marijuana menace,’” according to NPR. This elaborate fabrication clearly played to anti-immigrant and minority sentiment. These methods proved successful.

“That combo led to restrictions in state after state, ultimately resulting in federal prohibition,” the article continued.

marijuana joint
Photo by Wavebreakmedia/Getty Images

This campaign may have occurred nearly 100 years ago, but it can be argued that its effects are still felt today. It is widely known that arrests associated with marijuana are racially disproportionate. “Despite roughly equal usage rates, Blacks are 3.73 times more likely than whites to be arrested for marijuana,” according to the ACLU. 

RELATED: High Vs. Stoned: Is There A Difference?

Fear tactics and racism birthed the word marijuana, and also helped lead to it becoming illegal on a federal level, but the tide continues to shift. “Today ‘cannabis’ and ‘marijuana’ are terms used more or less interchangeably in the industry, but a vocal contingent prefers the less historically fraught ‘cannabis,’” wrote The Guardian.

Perhaps now as the country continues to legalize the substance, and society continues to want to improve upon its racist and problematic mistakes, it is time to say goodbye to marijuana and just stick to cannabis, the way we did before this whole marijuana madness began.

Will Mississippi’s Governor Sign Medical Marijuana Bill? Does It Even Matter?

Reeves told reporters at the Capitol that as the deadline approaches, his attorneys are still reviewing the bill.

By Maureen Meehan

Mississippi Gov. Tate Reeves said Tuesday he’s yet to decide whether he will sign a bill to legalize medical marijuana for people with debilitating medical conditions such as cancer, AIDS and sickle cell disease.

Regardless of the governor’s decision, the bill is expected to become law because the GOP-led House and Senate passed it last week by veto-proof majorities.

Mississippi
Photo by Pieter van de Sande via Unsplash

RELATED: Mississippi Lawmakers Advance Medical Cannabis Bill To Governor’s Desk

Nearly 75% of Mississippi voters approved a medical marijuana initiative in November 2020. Yet after the overwhelming vote, the state Supreme Court proceeded to invalidate the initiative six months later by ruling the process was outdated and the measure was not properly placed on the ballot.

Anger and confusion ensued. NORML’s state policies manager Carly Wolf called the ruling “overtly undemocratic tactics,” which should make Americans furious.

Now, eight months later, Reeves said he likes that the bill requires parental consent and a doctor’s permission for patients younger than 18 to obtain marijuana — a requirement that essentially exists in every legal medical marijuana state.

To Sign Or Not To Sign, That Is The Question

The deadline is upon the governor to act on the bill: sign, veto or let it become law.

Reeves told reporters at the Capitol that as the deadline approaches, his attorneys are still reviewing the bill, and he was pleased legislators made some of the changes he suggested, including reducing the amount of marijuana available to patients each month.

RELATED: More Red States Are Going Wild For Weed

“The process doesn’t always work, but the process has worked in this particular instance,” Reeves said.

This article originally appeared on Benzinga and has been reposted with permission.

Despite Health Risks, The Use Of This Sleeping Aid Has Increased Over The Years

0

Even though melatonin is an over-the-counter medicine, not enough is known about it for people to be consuming it so comfortably.

Sleep disorders are incredibly common, affecting about 70 million Americans a year. Medications and other substances that treat sleep are increasingly common, although with some concerning side effects that might impact sleep in the long term.

One of the most harmless solutions to this is melatonin, a compound that’s been growing in popularity over the years. Still, when used at high levels, it has a certain amount of risks.

According to a new study, melatonin use has increased over the past few years, increasing by more than twice the amount consumed a decade ago.

This Sleep Disorder Has Been Associated With Depression
Photo by Sharon McCutcheon via Unsplash

RELATED: Is CBN Going To Give Melatonin A Run For Its Money?

The study, published in JAMA Network, argues that even though melatonin is an over-the-counter medicine, not enough is known about it for people to be consuming it so comfortably. Despite the fact that people view it as a natural herb, the reality is that melatonin is a hormone. The consumption of it is so widespread that companies advertising it as a sleep aid vary wildly in the amount of melatonin per gram, at times providing more than the standard 5mg a day dosage that’s recommended for providing quick relief in sleep problems.

According to the NIH, melatonin has been linked with headaches, dizziness, nausea, irritability, anxiety and depression, and is capable of interacting with other medications. “We cannot be certain of the purity of melatonin that is available over the counter,” sleep specialist Rebecca Robbins told CNN.

While it appears that in the short term melatonin provides useful benefits, its long-term use is much more complex than a harmless pill that can put you to bed.

RELATED: Why The Latest Study Saying Cannabis Is Bad For Sleep Is Deeply Flawed

Melatonin is helpful depending on the person taking it. While it may work for some, it might not for others, and should always be monitored, from the amount of it you consume to frequency, to the brand you’re using. In regards to pregnant women and children, it’s important to visit a doctor first, who can provide you with a more informed opinion than what you can find online.

Did Biden Forget His Promise To Decriminalize Weed? Here’s Why Advocates Are Concerned

The fact that Biden’s Commerce Sec. is not focused on marijuana legalization has provoked cannabis advocates to question the President’s willingness to keep his promise.

By Nina Zdinjak

President Joe Biden’s Commerce Secretary Gina Raimondo revealed in a recent interview with Politico that she has no updates on cannabis decriminalization that was promised during the presidential campaign, reported Marijuana Moment.

When a reporter asked if cannabis should be descheduled, pointing out that some businesses don’t want to see this as it would likely increase competition creating across state markets, Raimondo replied that the matter is “so far afield from anything that I’m working on.” As Raimondo’s focus continues to be trade and supply chain management, marijuana is apparently not yet on her agenda.

joe biden kamala harris
Photo by Chip Somodevilla/Getty Images

Just recently, a new poll conducted by YouGov and The Economist, revealed that more than half of the U.S. adult population concurs that President Biden has made little to no progress on his crucial campaign promise to decriminalize cannabis during his first year in office.

The survey revealed that the majority of U.S. residents also don’t hold out much hope that the president will make progress on this important reform in 2022, which is in line with Raimondo’s response.

RELATED: Most Americans Don’t Believe Biden Will Keep His Cannabis Decriminalization Promise

Interestingly, Raimondo, who was a governor of Rhode Island before joining the Biden administration, skillfully dealt with marijuana policies, backing a plan in her budget proposal to legalize recreational cannabis via a state-run model. Her successor, Gov. Dan McKee just recently proposed a measure in his budget that would support a more conventional recreational cannabis market.

The fact that Raimondo is not focused on marijuana legalization has provoked cannabis advocates to question the President’s willingness to keep his promise on cannabis decriminalization.

This article originally appeared on Benzinga and has been reposted with permission.

Congressional Climate Resilience Bill Includes Protecting Its Workforce From Cannabis Testing

The new bill recognizes that many states are lightyears ahead of the federal government when it comes to worker protections and rational policy when it comes to drug testing.

By Nina Zdinjak

A new bill seeking to promote climate resilience jobs and establish a White House Office of Climate Resilience to encourage climate protection work has been filed by a group of more than two dozen congressional Democrats, reports Marijuana Moment.

An important feature of the bill is that it’s designed to protect people in states with legal cannabis programs from being penalized because of federal drug testing protocols. Under the proposed measure, those employed in a state with legalized marijuana could not be denied training opportunities or work in climate resilience “on the basis of a federally mandated drug test that is more stringent than any drug test that is in place in the locality or State, or used by the union of such employee,” according to the text of the bill.

Photo by 400tmax/Getty Images

Those in states where cannabis is still illegal may still fall under the strict federal protocol.

“The innovative Climate Resilience Workforce Act responds to the worsening climate crisis at the scale necessary by investing in a skilled workforce that is capable of not only responding to but preparing for the destructive impacts of climate change,” Rep. Pramila  Jayapal (D-WA), chair of the Congressional Progressive Caucus said in a press release. “As we create millions of good-paying, union jobs and center the very communities who are disproportionately impacted, we are finally building back better, greener, and stronger.”

RELATED: How Cannabis Legalization Is Changing The American Workplace

Among 30 other Congress members who back the legislation are Reps. Alexandria Ocasio-Cortez (D-NY) Earl Blumenauer (D-OR), Jamaal Bowman (D-NY), Cori Bush (D-MO), Mondaire Jones (D-NY) Barbara Lee (D-CA), Jerrold Nadler (D-NY), Eleanor Holmes Norton (D-DC), Ayanna Pressley (D-MA) and Rashida Tlaib (D-MI).

Advocate Response

“This new bill keenly recognizes that many states, including those that are most at risk to the harms of climate change, are lightyears ahead of the federal government when it comes to worker protections and rational policy when it comes to drug testing for trace metabolic elements,” Justin Strekal, former NORML lobbyist who recently founded Useful Strategies told Marijuana Moment. “As long as the Reagan-Era Executive Order to require testing remains in place, this type of congressional action is essential to moving policy in the right direction.”

This article originally appeared on Benzinga and has been reposted with permission.

What To Know About Weed In The 2022 Workplace

The waters are getting murky for employers who have workers who are medical marijuana patients. Here’s what you should know.

The landscape surrounding the legality of cannabis throughout the United States has left both employees and employers in a state of uncertainty. This uncertainty persists because the changes regarding cannabis laws take effect so fast.

Unfortunately, when parties are left in the dark regarding the rules and regulations of cannabis consumption, surprises happen. Typically for employees, those surprises come in the form of random drug tests that could result in unemployment. That’s why it’s important to keep a few essential caveats in mind when consuming marijuana even in states where it’s completely legal.

Here are some important insights to keep in mind regarding weed in the workplace.

office
Photo by Marc Mueller from Pexels

Going to Work Under the Influence Can Still Result in Termination

There are numerous circumstances that could tempt an employee to head to work under the influence. From an overwhelming amount of responsibilities to an influx of unpleasant customers or clients, there are a wide variety of reasons why taking a massive bong rip prior to work is seen as a necessity for employees.

RELATED: An Essential Legal Marijuana Guide For US Employers — Here Are The Rules

Since employers have the right to terminate workers who are thought to be under the influence, it’s advisable for overworked employees to decide on a different method to relieve themselves from the pressures that come with the job. Doing so could be a safeguard against the stress that comes with searching for a new job while bills continue to pile up.

Federal Prohibition of Cannabis Means Employers Can Maintain-Zero Tolerance Policies

One of the reasons why employers are still able to fire employees for cannabis use on the job, even in legal states, is due to the federal prohibition of cannabis. This allows workplaces to require that their employees sign off on an agreement to contribute to making the job a drug-free workplace.

Another reason that gives employees the ability to fire employees for cannabis use is tying it into a decline in workplace performance. Industries that are performance-based are well within their rights to fire employees that affect the bottom line, or the performance of other employees due to cannabis use. This is especially true if the cannabis use that affects employee performance takes place on the clock. The only time employers would have cause for pause in said scenario is when dealing with an employee with a medical marijuana card.

RELATED: Smoking Weed After Work Doesn’t Affect Job Performance, Study Finds

Cannabis For Mental Health In The Workplace — How Canada Is Showing Us The Way
Photo by Campaign Creators via Unsplash

A Medical Marijuana Card May Provide Special Accommodations For Those who Qualify

People who require medical marijuana to perform routine tasks to get through the day are the ones most likely to be afforded special privileges regarding marijuana use in the workplace. There are a variety of conditions that could qualify someone for a medical marijuana card too, depending on the state. Some of the most common qualifying conditions include HIV/AIDS, glaucoma and multiple sclerosis. This means employers need to be careful about imposing drug testing requirements on those who qualify for it.

RELATED: How Cannabis Legalization Is Changing The American Workplace

The best way to do this is by learning if there are any employees who are members of a state’s medical marijuana card program. Some states have laws that are designed to protect medical marijuana patients from discrimination, so employers should take special care to ensure they don’t discriminate against these employees by imposing their drug-free workplace policies. 

Can Cannabis Prevent & Treat Concussions? NFL Gives Researchers $500K To Find Out

Researchers will look at pain management and chronic pain in those suffering from post-concussion syndrome, and examine CBD/THC as a neuroprotective treatment for concussion.

By Jelena Martinovic

University of Regina‘s Dr. Patrick Neary received more than $500,000 from the National Football League (NFL), along with $400,000 of in-kind support from My Next Health Inc. to investigate the use of cannabinoids to treat concussions and alleviate and manage pain.

Dr. Neary, an exercise physiologist and prof in Kinesiology and Health Studies at the University of Regina, Canada, has been working in the area of concussion prevention and treatment for more than 15 years. He says he’s excited to have the NFL’s support.

football sports
Photo by anton5146/Getty Images

The Research

Neary says the research team will investigate the effects of different CBD/THC formulations, which are being provided by My Next Health Inc. Researchers will look at pain management and chronic pain in those suffering from post-concussion syndrome. They will also examine CBD/THC as a neuroprotective treatment for concussion.

RELATED: Is Cannabis Better For Sports Injuries Than Traditional Painkillers?

“We anticipate our CBD/THC formulation will show significant and positive changes to what it does to the brain – that it will reduce pain and use of prescription medications (opioids), show a reduced number of concussions during athletic competition and provide physiological and psychological benefits,” Neary said.

The Canada-wide team includes physicians, cardiologists, psychologists, pharmacologists, neuroscientists and researchers from other fields.

Preparatory work for the project will begin immediately; next steps will include obtaining Health Canada approval for the clinical trials.

RELATED: Your Brain On Weed: Concussions And Cannabis

“As with the league’s broader approach to health and safety, we want to ensure that our players are receiving care that reflects the most up-to-date medical consensus,” said Dr. Allen Sills, the NFL’s chief medical officer. “While the burden of proof is high for NFL players who want to understand the impact of any medical decision on their performance, we are grateful that we have the opportunity to fund these scientifically-sound studies on the use of cannabinoids that may lead to the discovery of data-based evidence that could impact the pain management of our players,” Sills added.

This article originally appeared on Benzinga and has been reposted with permission.

Here’s How Getting High Affects Your Driving, According To New Study

A new study finds that weed impairs drivers, hours after they’ve gotten high.

Cannabis’ effect on drivers is not wholly understood. While THC use impairs drivers, researchers and law enforcers are not clear on the amount of cannabis that needs to be in someone’s system for there to be impairment. They’re also not clear on how long cannabis leaves a person impaired for driving.

A new study narrowed down the time frame of cannabis impairment, discovering that people are usually fit for driving four hours after they consumed cannabis.

RELATED: Study: Consuming CBD-Rich Cannabis Has ‘No Significant Impact’ On Driving

Study Finds CBD Doesn't Impair Driving And THC's Effects Fade Within Hours
Photo by Jed Villejo via Unsplash

Published in the JAMA Psychiatry journal, the study was conducted by researchers from the University of California. They looked at 191 regular cannabis users and did simulated driving tests on them, finding that cannabis consumption significantly declined their capability to drive.

Participants were split up into two groups: one that ingested a placebo and another that contained cannabis with either 5.9% or 13.4% of THC. Researchers measured impairment at different points of the study.

Broadly, results showed that participants who consumed THC performed lower in their Composite Drive Scores (CDS), which tested them on a variety of skills like following cars at varying speeds, responding to dividing attention tasks, and more.

Results are interesting upon closer look. While all cannabis consumers were reticent to driving right after consuming cannabis, 69% of them said they were ready to drive an hour and a half after consuming cannabis. Their CDS scores were low, showing that even though they thought they were ready to drive, their bodies remained impaired.

“Although users in the THC group felt impaired and were hesitant to drive at 30 minutes, by 1 hour-30 minutes they believed the impairment was wearing off and were more willing to drive. This was despite their performance not significantly improving from the 30 minute point,” said the study’s lead author, Thomas Marcotte.

Lastly, researchers found that at the 4-hour mark there was no difference between the placebo group and the cannabis group.

RELATED: Scientists Develop On-Site Test For Cannabis Use Similar To A Breathalyzer

is new marijuana breathalyzer technology on the way
Photo by JasonDoiy/Getty Images

Another interesting discovery the study made was the lack of correlation between blood concentrations and driving performance, something that we’ve written about in the past and that’s become the reason why a functioning cannabis breathalyzer will likely never get made. It appears that cannabis is a highly individualized experience; while someone may have high cannabis levels in their blood, they might not be as impaired as someone who has low levels of THC in their bloodstream and perhaps less experience with the drug.

This study provides a deeper understanding of how cannabis works in our systems and how it impairs drivers differently than alcohol, something that’s important to understand as cannabis earns legalization across states.

Not So Fast With The Cannabis-COVID Treatment: Researchers Clarify

The truth behind how cannabinoids and terpenes work in therapeutic mixtures is more complicated than has been reported in the popular press.

By Nina Zdinjak

Following the promising study on cannabinoids and COVID-19 published by Oregon State University, Gb Sciences, Inc., a plant-based biopharmaceutical research and development company, has advised that the truth behind how cannabinoids and terpenes work in therapeutic mixtures is more complicated than has been reported in the popular press.

Gb Sciences’ study with Michigan State University (MSU) has yielded preclinical data demonstrating that specific compounds and ratios of those cannabis compounds are likely to be required for cannabinoids to be used to treat COVID-19 symptoms.

cannabis covid
Photo by Yarygin/Getty Images

Gb Science recently reported additional study data that supports the potential of cannabinoids as a treatment option for hyperinflammation resulting from COVID-19. Gb Sciences and an MSU researcher evaluated the potential for cannabis-derived compounds to suppress immunological responses that contribute to COVID-19 symptoms. Their study and conversations have received media coverage across the country based on an interview with the MSU researcher that broke from WLNS-TV in Lansing, Michigan, and interviews with Gb Sciences in the magazines Cannabis Business Times and Hemp Grower.

RELATED: High-Purity CBD May Help Block COVID-19 From Replicating, New Study Suggests

In the WLNS-TV interview, Norbert Kaminski, Ph.D., a researcher and professor of pharmacology and toxicology at MSU, reported that his partnership with Gb Sciences has explored the potential for certain compounds, cannabinoids and terpenes from the cannabis plant to decrease the human inflammatory responses to COVID-19, but that this specific drug will still need time to be studied to validate both the types of compounds and their specific ratios in mixtures that will successfully battle hyperinflammation triggered by COVID-19.

“By adding these various mixtures, and different combinations, we’re able to assess whether those compounds are effective in potentially helping people resolve breathing problems that are associated with the virus,” Kaminski said.

Smoking Weed Won't Protect You From COVID-19
Photo by Jeff W via Unsplash

RELATED: OSU Study Finds CBGA And CBDA Block COVID-19 Virus

The study is in its early stages but, in the WLNS coverage, Kaminski said both teams are hopeful about its progress thus far.

“It really is the only kind of plant that I’m aware of that makes these molecules,” Kaminski added.

This article originally appeared on Benzinga and has been reposted with permission.

Drinking This Could Lower Your COVID-19 Risk

0

A new study found that people who consumed this drink had a slight protection against COVID-19 infection.

Sadly, drinking alcohol is rarely associated with health benefits. One study, however, found that consuming red wine could provide certain protections against COVID-19.

The study, published on the journal Frontiers in Nutrition, examined data from the British database UK Biobank. The research showed that people who consumed five or more glasses of red wine per week were 17% less likely to become infected with COVID-19. Researchers theorize that this is due to the drink’s polyphenol content.

RELATED: High-Purity CBD May Help Block COVID-19 From Replicating, New Study Suggests

wine
Photo by Terry Vlisidis via Unsplash

While red wine provided the most benefits out of all the drinks that were surveyed, alcoholic drinks like white wine and champagne also provided protection against the virus, with people who consumed it as their beverage of choice being 8% less likely to develop COVID-19.

This is as far as good news gets. People who consumed beers and cider showed the opposite effect than those who consumed wine and champagne: these imbibers were 28% more likely to get infected by COVID-19.

Red wine has long been associated with benefits like lowering bad cholesterol, promoting heart health, and being rich in antioxidants. Up to one drink a day is considered drinking in moderation, and is something that could boost people’s systems and be a part of an enjoyable daily routine.

RELATED: Does Omicron Cause Loss Of Smell And Taste? Here’s What A New Study Says

Despite wine and champagne’s protective qualities, these drinks are still not enough to protect you fully from COVID-19, especially if you’re consuming too many of them. At the end of the day, alcohol is alcohol, and large amounts of it could depress your immune system and result in a variety of illnesses and conditions that can be harmful in the long run.

In order to stay safe, experts recommend staying up to date with your vaccines and keeping an eye on the COVID-19 transmission rates in your area, which should inform you on what’s safe and what isn’t safe to do.

Don't Miss Your Weekly Dose of The Fresh Toast.

Stay informed with exclusive news briefs delivered directly to your inbox every Friday.

We respect your privacy. Unsubscribe anytime.